Literature DB >> 16908173

Synthesis and immunosuppressive activity of new artemisinin derivatives. Part 2: 2-[12(beta or alpha)-dihydroartemisinoxymethyl(or 1'-ethyl)]phenoxyl propionic acids and esters.

Zhong-Shun Yang1, Jun-Xia Wang, Yu Zhou, Jian-Ping Zuo, Ying Li.   

Abstract

Another series of novel dihydroartemisinin derivatives were synthesized and assessed for their cytotoxicity of lymphocyte, inhibitory activity on mitogen-induced spleen lymphocyte proliferation in vitro. Some of the compounds exhibited inhibitory effects on ConA-induced T cell and LPS-induced B cell proliferation comparable to or more potent than parent artemisinin.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16908173     DOI: 10.1016/j.bmc.2006.07.038

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  12 in total

Review 1.  Immune suppressive properties of artemisinin family drugs.

Authors:  Lifei Hou; Haochu Huang
Journal:  Pharmacol Ther       Date:  2016-07-10       Impact factor: 12.310

2.  Investigation of the immunosuppressive activity of artemether on T-cell activation and proliferation.

Authors:  J-X Wang; W Tang; L-P Shi; J Wan; R Zhou; J Ni; Y-F Fu; Y-F Yang; Y Li; J-P Zuo
Journal:  Br J Pharmacol       Date:  2007-01-29       Impact factor: 8.739

Review 3.  Artemisinin derivative SM934 in the treatment of autoimmune and inflammatory diseases: therapeutic effects and molecular mechanisms.

Authors:  Xiao Tong; Li Chen; Shi-Jun He; Jian-Ping Zuo
Journal:  Acta Pharmacol Sin       Date:  2022-09-01       Impact factor: 7.169

Review 4.  Artemisinin and its derivatives: a potential therapeutic approach for oral lichen planus.

Authors:  Rui-Jie Ma; Ming-Jing He; Ya-Qin Tan; Gang Zhou
Journal:  Inflamm Res       Date:  2019-02-01       Impact factor: 4.575

Review 5.  Qinghaosu (artemisinin): chemistry and pharmacology.

Authors:  Ying Li
Journal:  Acta Pharmacol Sin       Date:  2012-08-27       Impact factor: 6.150

6.  SM905, an artemisinin derivative, inhibited NO and pro-inflammatory cytokine production by suppressing MAPK and NF-kappaB pathways in RAW 264.7 macrophages.

Authors:  Jun-Xia Wang; Li-Fei Hou; Yang Yang; Wei Tang; Ying Li; Jian-Ping Zuo
Journal:  Acta Pharmacol Sin       Date:  2009-10       Impact factor: 6.150

7.  The new water-soluble artemisinin derivative SM905 ameliorates collagen-induced arthritis by suppression of inflammatory and Th17 responses.

Authors:  J-X Wang; W Tang; R Zhou; J Wan; L-P Shi; Y Zhang; Y-F Yang; Y Li; J-P Zuo
Journal:  Br J Pharmacol       Date:  2008-02-11       Impact factor: 8.739

Review 8.  Anti-inflammatory and immunoregulatory functions of artemisinin and its derivatives.

Authors:  Chenchen Shi; Haipeng Li; Yifu Yang; Lifei Hou
Journal:  Mediators Inflamm       Date:  2015-04-16       Impact factor: 4.711

9.  Artesunate abolishes germinal center B cells and inhibits autoimmune arthritis.

Authors:  Lifei Hou; Katharine E Block; Haochu Huang
Journal:  PLoS One       Date:  2014-08-12       Impact factor: 3.240

10.  A Rational Active-Site Redesign Converts a Decarboxylase into a C=C Hydratase: "Tethered Acetate" Supports Enantioselective Hydration of 4-Hydroxystyrenes.

Authors:  Stefan E Payer; Hannah Pollak; Silvia M Glueck; Kurt Faber
Journal:  ACS Catal       Date:  2018-02-07       Impact factor: 13.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.